Gregory Cairncross

5.4k citations
42 papers · 3.9k · 2 hit papers · h-index 21

Impact in

  • Genetics top 0.1%
    • Glioma Diagnosis and Treatment
    • Virus-based gene therapy research
    • Cancer, Hypoxia, and Metabolism
    • Cancer Genomics and Diagnostics

Papers in

    • Glioma Diagnosis and Treatment 33
    • Histone Deacetylase Inhibitors Research 4
    • Epigenetics and DNA Methylation 3

Gregory Cairncross

41 papers receiving 3.8k citations

Gregory Cairncross's Hit Papers

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 2012 · 822 citations
8220+6+13Years since publication250500750

Peers

Gregory Cairncross
Comparison fields: 5 of 88
  • Genetics 3.0k
  • Cancer Research 530
  • Neurology 528
  • Pulmonary and Respiratory Medicine 1.0k
  • Radiology, Nuclear Medicine and Imaging 459
Replace Karen Fink with:
Karen Fink United States
Florence Laigle–Donadey France
Yannick Marie France
Alicia Tosoni Italy
Janet M. Bruner United States
Hendrikus J. Dubbink Netherlands
Sumihito Nobusawa Japan
Masato Kochi Japan
Dieta Brandsma Netherlands
Girish Dhall United States
Gregory Cairncross relative to Karen Fink United States Karen Fink's profile →
Citations per field
00.5×1.5×
Karen Fink · 1×
Citations per year

Countries citing papers authored by Gregory Cairncross

Since Specialization
Citations

This map shows the geographic impact of Gregory Cairncross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Cairncross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Cairncross more than expected).

Fields of papers citing papers by Gregory Cairncross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Cairncross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Cairncross. The network helps show where Gregory Cairncross may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory Cairncross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory Cairncross Line = papers co-authored together Gregory Cairncross links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
Hit paper breakdown →
2012822
2
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
Hit paper breakdown →
2006550
3 2006407
4 1994366
5 1997311
6 2002307
7 2008237
8 2013170
9 1999124
10 2008103
11 200476
12 200868
13
Low grade glioma: a measuring radiographic response to radiotherapy.
199956
14 200942
15 199636
16 200134
17 200027
18 200825
19 199520
20 200420

About Gregory Cairncross

Gregory Cairncross is a scholar working on Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Neurology and Ophthalmology, having authored 42 papers that have together received 3.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (5 papers), Histone Deacetylase Inhibitors Research (4 papers), Ocular Oncology and Treatments (4 papers), Neuroblastoma Research and Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), Neurogenesis and neuroplasticity mechanisms (2 papers) and Neurofibromatosis and Schwannoma Cases (2 papers). The work is most often cited by research in Genetics (3.0k citations), Cancer Research (530 citations), Neurology (528 citations), Pulmonary and Respiratory Medicine (1.0k citations) and Radiology, Nuclear Medicine and Imaging (459 citations). Gregory Cairncross has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Normand Laperrière, Robert B. Jenkins, Jan C. Buckner, Luís Souhami, David Brachman, Minesh P. Mehta, Edward Shaw, Karen Fink, Lisa Zuraw and David Macdonald. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Neuro-Oncology, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques and Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact